Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited has issued a positive profit alert, indicating an expected net profit of approximately RMB1.85 billion for the first half of 2025, up from RMB1.49 billion in the same period in 2024. This increase is largely attributed to a significant license fee income from Novo Nordisk A/S, despite declines in segment profits for intermediate products and bulk medicine.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily involved in the pharmaceutical industry. It focuses on the production and distribution of intermediate products and bulk medicines.
YTD Price Performance: 33.17%
Average Trading Volume: 15,699,776
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.53B
Find detailed analytics on 3933 stock on TipRanks’ Stock Analysis page.